Balversa 4MG
Ended Awarded Last action
- Contract number
- 36C25023F0608
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,046
Award facts
- Contract value 100% obligated
- $17,046.33 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Horsham, PA 19044, USA
Award details come from SAM.gov/FPDS.
About this award
Janssen Biotech, Inc. was awarded a $17,046.33 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract vehicle by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The firm fixed price order is for the drug BALVERSA 4MG and has a period of performance through May 12, 2023. No set-aside provisions were applied to this order. The Veterans Health Administration procures pharmaceuticals through its medical facilities to provide healthcare services to veterans. Janssen Biotech will deliver the cancer treatment BALVERSA to the Veterans Integrated Service Network 10 region, with a place of performance in Horsham, Pennsylvania, in support of the Veterans Health Administration's mission.
Quick answers
Who was awarded contract 36C25023F0608?
36C25023F0608 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on April 10, 2023.
How much is contract 36C25023F0608 worth?
The government has obligated $17,046 on 36C25023F0608.
Is contract 36C25023F0608 an order under another contract?
Yes. 36C25023F0608 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25023F0608 competed?
The extent of competition for 36C25023F0608 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award